RES200 Pill - white capsule/oblong
Generic Name: delavirdine
Pill with imprint RES200 is White, Capsule/Oblong and has been identified as Rescriptor 200 mg. It is supplied by ViiV Healthcare.
Rescriptor is used in the treatment of HIV Infection and belongs to the drug class NNRTIs. Risk cannot be ruled out during pregnancy. Rescriptor 200 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for RES200
Rescriptor
- Generic Name
- delavirdine
- Imprint
- RES200
- Strength
- 200 mg
- Color
- White
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- NNRTIs
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- ViiV Healthcare
- National Drug Code (NDC)
- 49702-0225 (Discontinued)
- Inactive Ingredients
-
carnauba wax,
silicon dioxide,
croscarmellose sodium,
lactose anhydrous,
magnesium stearate,
microcrystalline cellulose
Note: Inactive ingredients may vary.
More about Rescriptor (delavirdine)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: NNRTIs
- Breastfeeding
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
